<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_UST_Beijing_Background skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:UST Beijing/Background</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Team:UST_Beijing/Collaborations</TITLE></P><DIV class="header"><DIV class="container"><NAV id="main_menu"><DIV class="nav-collapse collapse"><UL class="nav nav-pills"><LI><A href="https://2018.igem.org/Team:UST_Beijing">Home</A></LI><LI class="dropdown"><A href="javascript:{}">Team</A></LI><LI><A href="https://2018.igem.org/Team:UST_Beijing/Team">Team member</A></LI></UL><LI class="dropdown active"><A href="javascript:{}">Project</A></LI><LI><A href="https://2018.igem.org/Team:UST_Beijing/Background">Background</A></LI><LI><A href="https://2018.igem.org/Team:UST_Beijing/Experiments">Experiments</A></LI><LI><A href="https://2018.igem.org/Team:UST_Beijing/Notebook">Notebook</A></LI><LI><A href="https://2018.igem.org/Team:UST_Beijing/Model">Model</A></LI><LI><A href="https://2018.igem.org/Team:UST_Beijing/Parts">Parts</A></LI><LI><A href="https://2018.igem.org/Team:UST_Beijing/Safety">Safety</A></LI><LI class="dropdown"><A href="javascript:{}">Awards</A></LI><LI><A href="https://2018.igem.org/Team:UST_Beijing/Attributions">Attribution</A></LI><LI><A href="https://2018.igem.org/Team:UST_Beijing/Collaborations">Collaboration</A></LI><LI><A href="https://static.igem.org/mediawiki/2018/5/5a/T--UST_Beijing--Demonstrate.pdf">Demonstrate</A></LI><LI><A href="https://2018.igem.org/Team:UST_Beijing/InterLab">InterLab</A></LI><LI><A href="https://2018.igem.org/Team:UST_Beijing/Human_Practices">HumanPractice</A></LI><LI><A href="https://2018.igem.org/Team:UST_Beijing/Improve">Improve</A></LI></DIV></NAV></DIV></DIV><DIV id="banner"><DIV class="container intro_wrapper"><DIV class="inner_content"><H1 class="title"><SPAN class="hue">Background</SPAN></H1><A href="https://static.igem.org/mediawiki/2018/9/9d/T--UST_Beijing--bg.pdf" class="btn btn-info  btn-large btn-rounded">CLICK FOR PDF</A></DIV></DIV></DIV><DIV class="container wrapper"><DIV class="inner_content"><DIV class="row"><DIV class="span6"><DIV><BLOCKQUOTE><H2><SPAN>Cholesterol</SPAN></H2><H3>an essential component of membrane structure, but gradually 
              accumulates in arteries of human body, which becomes the top one killer mechanism of human life: <SPAN>atherosclerosis</SPAN></H3><H2><SPAN> An alarming health threat: Atherosclerosis</SPAN></H2><H3>Shown on the right are the cholesterol structure and pie charts of epidemic statistics of atherosclerosis-related mortality in China (black area: atherosclerosis-related death).</H3></BLOCKQUOTE></DIV></DIV></DIV><DIV class="row"><DIV class="span6"><H2><SPAN>Pathology of Atheroscleosis</SPAN></H2><H3>Cholesterol is the main culprit of cardio-and cerebro-vascular disease. Artery atherosclerosis refers to arteries accumulated with cholesterol resulting in blockage of blood flow. In heart it causes heart attack. In brain it causes blockage stroke.</H3></DIV><DIV class="span6"><H2><SPAN>Molecular Mechanism of Atherosclerosis Formation</SPAN></H2><H3>Because of foam cell apoptosis, which is formed by macrophages overloading cholesterol, cholesterol is deposited on the inner wall of artery.</H3></DIV></DIV><DIV class="row"><DIV class="span6"><H2><SPAN>Nuclear receptor LXR as therapeutic target against atherosclerosis</SPAN></H2><H3>Live X receptor(LXR) functions as a master regulation switch, which can accelerate the transport of cholesterol and prevent the formation of foam cells.</H3></DIV><DIV class="span6 pad10"><H2><SPAN> Actions of LXR </SPAN></H2><H3>LXRs have a typical nuclear receptor structure. Upon bound by agonists (such as ginseno-sterols), LXRs would recruit co-activators (shown in the animation, only a fragment of coactivator peptide is displayed)and activate the transcription of a target gene.</H3></DIV></DIV><DIV class="row"><H3>Ginseng triterpenes' structure is similar to that of cholesterol, therefore it has the potential of regulating LXRs.
      LXRs is a typical nuclear receptor. In the presence of co-regulators, bound by agonists (such as ginsenosides), LXRs could be demobilized to specific site on a target gene promoter region to activate transcription of the target gene. Ginsenosides or like could therefore regulate the metabolism of cholesterol. </H3></DIV><DIV class="row"><DIV class="span6 element category01" data-category="category01"><DIV class="item_description"><H1><SPAN>Ginsenoside TR1 modulatesLXR biological activity</SPAN></H1></DIV></DIV><DIV class="span6 element  category02" data-category="category02"><DIV class="item_description"><H1><SPAN>Atherosclerosis formation is delayedby ginsenosides in vivo</SPAN></H1></DIV></DIV></DIV><DIV id="footer2"><DIV class="container"><DIV class="row"><DIV class="span12"><DIV class="copyright"> UST_Beijing
          Â© 
          .igem.org </DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>